VivoSeq
Other

Pancreatectomy

5

Pipeline Programs↗

3

Active Trials↗

2

Companies Involved↗

Pancreatectomy is an early-stage landscape with 5 programs across 2 companies. The most active players are Revance Therapeutics, Inc., RECORDATI GROUP. 1 therapy is approved with 1 more in late-stage development.

Intelligence

Pipeline Metrics

Competitive Density

30/100

Pipeline Velocity

6/100

Mech. Concentration

33/100

Completion Rate

33/100

Attrition Rate

22/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

R

Revance Therapeutics, Inc.

1 program

Phase 2R

RECORDATI GROUP

1 program

Phase 3

Pipeline

Programs by Phase

Analysis

Modality Breakdown

67%

Small molecule

4 of 6 classified programs — the dominant modality here.

33%ALL OTHERSPeptide233%

Small molecule leads; the ring shows all 6 classified programs, each share of the total. Modality classified for 100% of 6 pipeline programs.

Analysis

Trial Status

9

clinical trials

Unknown status3 · 33%
Terminated2 · 22%
Completed1 · 11%
Active, not recruiting1 · 11%
Recruiting1 · 11%
Not yet recruiting1 · 11%

Clinical Trials

Trial Activity

9 trials

Pancreatic Head Resection or Total Pancreatectomy With Islet Autotransplantation in Patients With Periampullary Cancer and High Risk Profile for the Development of Postoperative Pancreatic Fistula
Recruiting·TTechnische Universität Dresden·Phase 3·NCT05843877·32 enrolled
Evaluation of the Efficacy of Intramuscular Islet Autograft After Extensive Pancreatectomy
Active, not recruiting·UUniversity Hospital, Lille·Phase 1/2·NCT02872571·35 enrolled
Safety and Feasibility of Radiofrequency-Assisted Robotic Distal Pancreatectomy (Attachable Coolingbis®)
Not yet recruiting·Hospital del Mar·N/A·NCT07687901·20 enrolled
Placebo Controlled Trial of SOM230 for the Reduction of Post-Pancreatectomy Fistula, Leak, and Abscess
Completed·MMemorial Sloan Kettering Cancer Center·Phase 3·NCT00994110·439 enrolled
Endoscopic Botulinum Toxin Injection in the Prevention of Postoperative Pancreatic Fistula Following Distal Pancreatectomy
Terminated·OOHSU Knight Cancer Institute·Phase 2·NCT04965311·4 enrolled
The Effect of Pancreatic Polypeptide on Insulin Requirements for Type 1 & Post-pancreatectomy Diabetic Patients
Terminated·JJohns Hopkins University·Phase 2·NCT00791076·8 enrolled
Human Versus Analogue Insulin in Patients After Pancreatectomy.
Unknown status·PPolish Society of Diabetology·Phase 4·NCT04690309·100 enrolled
Can Administration of Etamsylate Reduce Postpancreatectomy Hemorrhage
Unknown status·UUniversity of Sfax·N/A·NCT06190535·20 enrolled
The Effect of Preoperative Long Period Octreotide Combined With Postoperative Short Period Octreotide on the Complications After Pancreatectomy. A Prospective, Multicenter Clinical Trial
Unknown status·—·N/A·NCT03398941·150 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)